Work flow chart of participants and reference groups. Note. *) Based on published data from a cohort of vaccinated patients treated with anti-CD20 antibodies for Multiple Sclerosis [29] **) Data first published in the weekly report no 52/2022 by the Norwegian Institute of Public Health [30]
